CorMedix
CRMD
47 hedge funds and large institutions have $48.6M invested in CorMedix in 2019 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 13 closing their positions.
63% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 8
54% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 13
40% more capital invested
Capital invested by funds: $34.8M → $48.6M (+$13.9M)
18% more funds holding
Funds holding: 40 → 47 (+7)
7.32% more ownership
Funds ownership: 15.47% → 22.78% (+7.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less call options, than puts
Call options by funds: $3.62M | Put options by funds: $4.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$7.66M |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.92M |
| 3 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$2.59M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
+$1.31M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$1.38M |
| 2 |
Millennium Management
New York
|
-$1.34M |
| 3 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$940K |
| 4 |
Goldman Sachs
New York
|
-$751K |
| 5 |
TEE
Tibra Equities Europe
London,
United Kingdom
|
-$593K |
CRMD Hedge Fund Activity: Q2 2019 in Review
47 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q2 2019, worth a combined $48.6M — up 40% from $34.8M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new CRMD positions and 13 closed out — a net gain of 7 holders — while 13 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock, adding an estimated $7.66M. The largest seller was EAM Investors, exiting entirely with an estimated $1.38M sold.
- 47 institutional investors held CorMedix (CRMD) as of Q2 2019, up from 40 in Q1 2019.
- Funds reported $48.6M of CorMedix stock for Q2 2019, up 40% quarter-over-quarter.
- 20 funds opened new CorMedix positions in Q2 2019 and 13 closed out, a net change of +7 holders.
- The largest CorMedix buyer in Q2 2019 was BlackRock, an estimated $7.66M added.
- The largest CorMedix seller in Q2 2019 was EAM Investors, an estimated $1.38M sold.
Based on aggregated 13F filings for Q2 2019.